AbbVie
ABBV
#30
Rank
A$648.59 B
Marketcap
A$367.10
Share price
4.20%
Change (1 day)
29.50%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of March 2026 : -A$9.59 Billion

According to AbbVie's latest financial reports the company has -A$9.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-A$4.82 Billion-189.11%
2024-12-31$A$5.40 B-64.56%
2023-12-31$A$15.26 B-39.93%
2022-12-31$A$25.40 B19.31%
2021-12-31$A$21.29 B25%
2020-12-31$A$17.03 B-245.93%
2019-12-31$-A$11.68 Billion-2.65%
2018-12-31$-A$11.99 Billion-283.64%
2017-12-31$A$6.52 B1.51%
2016-12-31$A$6.43 B18.77%
2015-12-31$A$5.41 B154.41%
2014-12-31$A$2.12 B-57.73%
2013-12-31$A$5.03 B55.62%
2012-12-31$A$3.23 B-72.19%
2011-12-31$A$11.63 B-24.72%
2010-12-31$A$15.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$130.99 B-1,467.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.20 B-571.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.31 B-238.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.02 B-382.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$33.95 B-454.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$29.12 B-404.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$68.65 B-816.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$33.43 B-448.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$4.93 B-151.53%๐Ÿ‡บ๐Ÿ‡ธ USA